Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cintirorgon in advanced solid tumors
NCT02929862Phase 2Completed
- Sponsor
- Lycera
- Start
- Dec 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cintirorgon in solid tumor, non-small cell lung cancer (NSCLC), gastric cancer (GC), esophageal cancer, head and neck squamous cell carcinoma (HNSCC), sponsored by Lycera. Started Dec 2016; status: completed.
02
Drugs
cintirorgon
03
Conditions
solid tumornon-small cell lung cancer (NSCLC)gastric cancer (GC)esophageal cancerhead and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02929862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929862.